CAP Seeks New CEO to Lead Pathology’s Largest Standards-Setting Organization
The College of American Pathologists has opened a search for its next chief executive officer, a leadership transition that arrives as laboratory medicine is being reshaped by AI, digital pathology, and expanding molecular testing. The association, based in Northfield, Illinois, is the world’s largest organization of board-certified pathologists and represents more than 20,000 members.
This is not a ceremonial handoff. CAP sits at the center of laboratory quality oversight, education, and advocacy, and the next chief executive will inherit a mission-heavy enterprise with national reach, an international footprint, and a business model built on standards, testing, and professional credibility.
A Large Membership Organization With Laboratory Authority
Founded in 1946, CAP describes itself as the standard-setter for laboratory quality worldwide. Its accreditation program is widely regarded as the gold standard, and its proficiency testing operation is the largest of its kind, with more than 700 programs used by over 23,000 laboratories. The organization also offers education and represents pathologists before Congress and federal agencies, giving the CEO role unusual breadth across science, regulation, and professional policy.
CAP says it has about 650 staff, annual revenue of roughly $320 million, headquarters in Northfield, and an office in Washington, DC. Those numbers matter because the next chief executive will need to lead a complex professional association that operates more like a diversified enterprise than a narrow trade group. The leader will be expected to protect the core accreditation and proficiency businesses while creating room for new revenue streams.
A single sentence captures the pressure facing the organization: the laboratory business is being pulled simultaneously toward automation, data integration, and more complex diagnostics.
Strategy, Finance, and Digital Expansion Are Central to the Role
The board is looking for a chief executive who can set enterprise strategy, maintain financial vitality, and strengthen operations while responding to changing member needs. CAP’s priorities include a multi-year growth plan focused on revenue diversification and innovation, along with continued investment in its core accreditation and proficiency testing services.
The organization is also looking beyond its traditional base. The next CEO will be expected to pursue opportunities in data, AI-enabled diagnostics, digital pathology, and international markets. Those areas are becoming increasingly relevant as pathology workflows shift from glass slides and manual review toward digitally enabled interpretation, algorithm-assisted triage, and broader integration of computational tools into clinical decision-making.
For a standards-setting organization, the challenge is delicate. Innovation cannot come at the expense of credibility, especially in a field where laboratories depend on external quality systems to support diagnosis, treatment selection, and patient safety. The next CEO will need to balance commercial expansion with the professional authority that has made CAP influential in the first place.
Leadership Expectations Reflect a Regulated, High-Stakes Environment
The ideal candidate, as framed in the search, is a former CEO, president, division president, or general manager with full profit-and-loss responsibility of at least $100 million. CAP wants a leader who has managed multi-line operations in the United States and abroad, delivered revenue growth, improved margins, and built or commercialized data, digital, or technology-enabled businesses.
Experience in healthcare, diagnostics, or life sciences is preferred. So is a track record in partnerships, licensing deals, acquisitions, or other forms of business development. CAP is also seeking someone who has led transformation in a regulated environment and worked closely with an engaged board.
The personal profile is equally explicit: collaborative, low-ego, financially disciplined, and comfortable with high accountability. A bachelor’s degree is required, while an MBA, MPA, or equivalent is preferred. Those criteria point to a role that demands both scientific fluency and enterprise management. The association is not asking for a figurehead; it wants an operator who can guide a professional body through a market where diagnostic technology is changing faster than many health systems can absorb it.
Why the Search Matters for Pathology Practice
CAP’s influence extends well beyond its membership rolls. Its accreditation standards shape laboratory operations, and its proficiency testing programs help determine whether results can be trusted across thousands of clinical settings. In practice, that means the chief executive’s decisions can affect how laboratories measure quality, how pathologists adapt to new technologies, and how the profession speaks to regulators and lawmakers.
Digital pathology and molecular diagnostics are especially consequential here. As pathology becomes more data-rich, organizations like CAP will be pressed to define quality metrics, training expectations, and operational guardrails for systems that rely on software as much as human interpretation. A CEO who understands both enterprise economics and diagnostic medicine will be better positioned to keep those standards relevant.
There is also a broader workforce implication. Pathologists are being asked to do more with more complex information, while health systems want faster turnaround, tighter quality assurance, and stronger interoperability. Leadership at CAP will shape how the profession responds to those demands through accreditation, education, and advocacy.
Spencer Stuart Will Manage the Recruitment Process
Spencer Stuart is supporting the search. Applications and nominations are being directed to [email protected].
The opening leaves CAP at a consequential inflection point. Its next chief executive will not just oversee a membership association; the person in the job will be responsible for protecting one of laboratory medicine’s most influential institutions while pushing it into a period defined by computation, digitization, and global competition. The search itself signals that the organization expects the ground beneath pathology to keep moving.